4//SEC Filing
WINDSOR JAMES BRIAN 4
Accession 0000950170-24-027304
CIK 0001420565other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:06 PM ET
Size
8.0 KB
Accession
0000950170-24-027304
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
President and COO
Transactions
- Exercise/Conversion
Common Stock
2024-03-05+2,000→ 7,122 total - Exercise/Conversion
Series X Non-Voting Convertible Preferred
2024-03-05−2→ 0 total→ Common Stock (2,000 underlying)
Holdings
- 225(indirect: By son)
Common Stock
Footnotes (2)
- [F1]On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share ("Series X Preferred Stock") automatically converted into shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration.
- [F2]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
AILERON THERAPEUTICS INC
CIK 0001420565
Entity typeother
Related Parties
1- filerCIK 0001790933
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:06 PM ET
- Size
- 8.0 KB